• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞斯托霉素诱导的血小板定量聚集的pH依赖性:理论与实际意义——一种维持富血小板血浆pH值的新装置

The pH dependence of quantitative ristocetin-induced platelet aggregation: theoretical and practical implications-a new device for maintenance of platelet-rich plasma pH.

作者信息

Coller B S, Franza B R, Gralnick H R

出版信息

Blood. 1976 May;47(5):841-54.

PMID:4176
Abstract

Quantitative ristocetin-induced platelet aggregation of normal platelet-rich plasma (PRP) decreased with time after PRP preparation. An increase in p H of the PRP with time proved to be responsible for this finding. Diffusion of CO2from the plasma is the prime determinant of the change in pH. Since a complex combination of factors influences CO2 diffusion (surface area-to-volume relationship, capping, mixing, etc.) The change in pH is variable with time. Thus, quantitative ristocetin aggregation should be pH controlled. A simple device for maintaining PRP pH constant by control of the ambient pCO2 was designed and found effective in keeping both pH and quantitative ristocetin aggregation constant over a prolonged period of time. It can be adapted for use in platelet aggregation studies employing other reagents. The pH dependence of ristocetin-induced platelet aggregation is consistent with other data supporting an elctrostatic interaction between the platelet, von Willebrand factor, and ristocetin. We favor a model wherein ristocetin neutralizes some of the platelet's negative change and permits the von Willebrand factor to bridge sites on separate platelets to induce agglutination.

摘要

富含血小板的正常血浆(PRP)经瑞斯托霉素诱导的定量血小板聚集在PRP制备后随时间下降。结果证明,PRP的pH值随时间升高是导致这一现象的原因。血浆中二氧化碳的扩散是pH值变化的主要决定因素。由于多种因素的复杂组合会影响二氧化碳的扩散(表面积与体积的关系、封盖、混合等),pH值随时间变化不定。因此,瑞斯托霉素定量聚集应进行pH值控制。设计了一种通过控制环境pCO₂来保持PRP pH值恒定的简单装置,发现该装置能在较长时间内有效保持pH值和瑞斯托霉素定量聚集恒定。它可适用于使用其他试剂的血小板聚集研究。瑞斯托霉素诱导的血小板聚集对pH值的依赖性与其他支持血小板、血管性血友病因子和瑞斯托霉素之间存在静电相互作用的数据一致。我们倾向于一种模型,即瑞斯托霉素中和了血小板的一些负电荷变化,并使血管性血友病因子能够连接不同血小板上的位点以诱导凝集。

相似文献

1
The pH dependence of quantitative ristocetin-induced platelet aggregation: theoretical and practical implications-a new device for maintenance of platelet-rich plasma pH.瑞斯托霉素诱导的血小板定量聚集的pH依赖性:理论与实际意义——一种维持富血小板血浆pH值的新装置
Blood. 1976 May;47(5):841-54.
2
Proceedings: Variations in quantitative ristocetin platelet aggregation (RPA) with time after platelet rich plasma (PRP) preparation: association with alteration in pH.研究报告:富血小板血浆(PRP)制备后,定量瑞斯托霉素血小板聚集(RPA)随时间的变化:与pH值改变的关联
Thromb Diath Haemorrh. 1975 Nov 15;34(2):581-2.
3
Plasma and platelet von Willebrand factor defects in uremia.尿毒症患者血浆和血小板中血管性血友病因子缺陷
Am J Med. 1988 Dec;85(6):806-10. doi: 10.1016/s0002-9343(88)80025-1.
4
Studies on the mechanism of ristocetin-induced platelet agglutination. Effects of structural modification of ristocetin and vancomycin.瑞斯托菌素诱导血小板凝集机制的研究。瑞斯托菌素及万古霉素结构修饰的影响。
J Clin Invest. 1977 Aug;60(2):302-12. doi: 10.1172/JCI108778.
5
A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers.一种新的血管性血友病变异型(I型,纽约型):瑞斯托霉素诱导的血小板聚集增加,血浆血管性血友病因子包含完整范围的多聚体。
Blood. 1986 Jul;68(1):149-56.
6
Platelet-collagen interaction: inhibition by ristocetin and enhancement by von Willebrand factor-platelet binding.血小板与胶原蛋白的相互作用:受瑞斯托菌素抑制,受血管性血友病因子-血小板结合增强。
Blood. 1986 Oct;68(4):927-37.
7
The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility.瑞斯托菌素和血管性血友病因子对血小板电泳迁移率的影响。
J Clin Invest. 1978 May;61(5):1168-75. doi: 10.1172/JCI109032.
8
[Ristocetin induced platelet aggregation in children with nephrotic syndrome].[瑞斯托菌素诱导肾病综合征患儿血小板聚集]
Nihon Jinzo Gakkai Shi. 1990 Jun;32(6):659-66.
9
[Use of frozen thrombocytes for the determination of von willebrand factor with the aid of ristocetin].[利用冷冻血小板借助瑞斯托霉素测定血管性血友病因子]
Schweiz Med Wochenschr. 1979 Mar 17;109(11):399-402.
10
Inhibition of ristocetin-induced platelet agglutination by vancomycin.万古霉素对瑞斯托菌素诱导的血小板凝集的抑制作用。
Blood. 1977 Sep;50(3):397-406.

引用本文的文献

1
Near-infrared photobiomodulation of blood reversibly inhibits platelet reactivity and reduces hemolysis.近红外光生物调节血液可可逆地抑制血小板反应性并减少溶血。
Sci Rep. 2022 Mar 8;12(1):4042. doi: 10.1038/s41598-022-08053-y.
2
First Human Use of RUC-4: A Nonactivating Second-Generation Small-Molecule Platelet Glycoprotein IIb/IIIa (Integrin αIIbβ3) Inhibitor Designed for Subcutaneous Point-of-Care Treatment of ST-Segment-Elevation Myocardial Infarction.首例人体应用 RUC-4:一种非激活的第二代小分子血小板糖蛋白 IIb/IIIa(整合素 αIIbβ3)抑制剂,旨在用于 ST 段抬高型心肌梗死的皮下即时治疗。
J Am Heart Assoc. 2020 Sep;9(17):e016552. doi: 10.1161/JAHA.120.016552. Epub 2020 Aug 26.
3
The platelet: life on the razor's edge between hemorrhage and thrombosis.
血小板:处于出血与血栓形成之间的微妙平衡状态。
Transfusion. 2014 Sep;54(9):2137-46. doi: 10.1111/trf.12806. Epub 2014 Aug 5.
4
The role of platelet aggregation and release in fragment D-induced pulmonary dysfunction.血小板聚集和释放在D片段诱导的肺功能障碍中的作用。
Ann Surg. 1980 Jul;192(1):103-7. doi: 10.1097/00000658-198007000-00017.
5
A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.一种能完全阻断纤维蛋白原与血小板结合的鼠单克隆抗体,可使正常血小板产生类血小板无力症状态,并与糖蛋白IIb和/或IIIa结合。
J Clin Invest. 1983 Jul;72(1):325-38. doi: 10.1172/jci110973.
6
Effect of heparin and heparin fractions on platelet aggregation.肝素及肝素组分对血小板聚集的影响。
J Clin Invest. 1980 Jan;65(1):64-73. doi: 10.1172/JCI109661.
7
Platelet function and factor VIII in uremia.尿毒症中的血小板功能与凝血因子VIII
Korean J Intern Med. 1987 Jan;2(1):74-8. doi: 10.3904/kjim.1987.2.1.74.
8
A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.一种新的鼠单克隆抗体显示血小板糖蛋白IIb/IIIa复合物的构象和/或微环境存在激活依赖性变化。
J Clin Invest. 1985 Jul;76(1):101-8. doi: 10.1172/JCI111931.
9
Destruction of the platelet aggregating activity of ristocetin A.瑞斯托菌素A血小板聚集活性的破坏。
Experientia. 1978 Apr 15;34(4):532-4. doi: 10.1007/BF01935974.
10
Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.凝血因子VIII/血管性血友病因子蛋白。半乳糖是血管性血友病因子活性的一个隐蔽决定因素。
J Clin Invest. 1978 Aug;62(2):496-9. doi: 10.1172/JCI109152.